| Date Filed | Type | Description |
| 01/10/2023 |
4
| ANDREWS RONALD ASBURY (Director) has filed a Form 4 on Precipio, Inc.|
Txns:
| Granted 30,000 options to buy
@ $0.62, valued at
$18.6k
|
|
| 12/09/2022 |
4
| ANDREWS RONALD ASBURY (Former CEO) has filed a Form 4 on Oncocyte Corp|
Txns:
| Disposed/sold 20,000 options to buy
@ $2.1, valued at
$42k
Disposed/sold 45,000 options to buy
@ $2.4, valued at
$108k
Disposed/sold 950,000 options to buy
@ $2.51, valued at
$2.4M
Disposed/sold 50,000 options to buy
@ $1.68, valued at
$84k
Disposed/sold 500,000 options to buy
@ $5.34, valued at
$2.7M
Disposed/sold 300,000 options to buy
@ $1.15, valued at
$345k
Disposed/sold 93,750 options to buy
@ $1.15, valued at
$107.8k
Disposed/sold 35,000 restricted stock units
@ $0
Disposed/sold 250,000 restricted stock units
@ $0
Exercised 250,000 restricted stock units
@ $0
Granted 50,000 options to buy
@ $0.4644, valued at
$23.2k
|
|
| 08/18/2022 |
4
| ANDREWS RONALD ASBURY (President & CEO) has filed a Form 4 on Oncocyte Corp|
Txns:
| Bought 40,000 shares
@ $0.96, valued at
$38.4k
|
|
| 03/17/2022 |
4
| ANDREWS RONALD ASBURY (CEO) has filed a Form 4 on Oncocyte Corp|
Txns:
| Bought 50,000 shares
@ $1.283, valued at
$64.2k
|
|
| 03/17/2022 |
4
| ANDREWS RONALD ASBURY (CEO) has filed a Form 4 on Oncocyte Corp|
Txns:
| Granted 300,000 options to buy
@ $1.15, valued at
$345k
Granted 200,000 options to buy
@ $1.15, valued at
$230k
Granted 375,000 options to buy
@ $1.15, valued at
$431.3k
Granted 35,000 restricted stock units
@ $0
Granted 500,000 restricted stock units
@ $0 |
|
| 01/13/2022 |
4
| ANDREWS RONALD ASBURY (Director) has filed a Form 4 on Precipio, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.54, valued at
$61.6k
|
|
| 08/05/2021 |
4
| ANDREWS RONALD ASBURY (Director) has filed a Form 4 on Precipio, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.22, valued at
$80.5k
|
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| ANDREWS RONALD ASBURY (CEO) has filed a Form 4 on OncoCyte Corp|
Txns:
| Paid exercise price by delivering 25,873 shares
@ $0
Exercised 106,221 restricted stock units
@ $0 |
|
| 03/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/01/2021 |
4
| ANDREWS RONALD ASBURY (CEO) has filed a Form 4 on OncoCyte Corp|
Txns:
| Granted 500,000 options to buy
@ $5.34, valued at
$2.7M
|
|
| 08/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2020 |
4
| ANDREWS RONALD ASBURY (CEO) has filed a Form 4 on OncoCyte Corp|
Txns:
| Granted 106,221 restricted stock units
@ $0 |
|
| 04/01/2020 |
4/A
| ANDREWS RONALD ASBURY (CEO and President) has filed a Form 4 on OncoCyte Corp|
Txns:
| Bought 27,216 shares
@ $2.258, valued at
$61.5k
Bought 18,000 shares
@ $2.372, valued at
$42.7k
|
|
| 04/01/2020 |
4
| ANDREWS RONALD ASBURY (CEO and President) has filed a Form 4 on OncoCyte Corp|
Txns:
| Bought 27,216 shares
@ $2.258, valued at
$61.5k
Bought 18,000 shares
@ $2372, valued at
$42.7M
|
|
| 07/03/2019 |
4
| ANDREWS RONALD ASBURY (CEO) has filed a Form 4 on OncoCyte Corp|
Txns:
| Granted 950,000 options to buy
@ $2.51, valued at
$2.4M
|
|
| 06/19/2019 |
4
| ANDREWS RONALD ASBURY (Director) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Granted 7,457 options to buy
@ $14.44, valued at
$107.7k
|
|
| 09/04/2018 |
4
| ANDREWS RONALD ASBURY (Director) has filed a Form 4 on OncoCyte Corp|
Txns:
| Granted 45,000 options to buy
@ $2.4, valued at
$108k
|
|
| 07/31/2018 |
4
| ANDREWS RONALD ASBURY (Director) has filed a Form 4 on OncoCyte Corp|
Txns:
| Bought 17,482 shares
@ $0
Bought 17,482 warrants
@ $3, valued at
$52.4k
|
|
| 06/21/2018 |
4
| ANDREWS RONALD ASBURY (Director) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Granted 7,457 options to buy
@ $14.49, valued at
$108.1k
|
|
| 04/12/2018 |
3
| ANDREWS RONALD ASBURY (Director) has filed a Form 3 on OncoCyte Corp |
| 06/08/2017 |
4
| ANDREWS RONALD ASBURY (Director) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Granted 7,457 options to buy
@ $14.46, valued at
$107.8k
|
|
| 06/29/2016 |
4
| ANDREWS RONALD ASBURY (Director) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Granted 7,457 options to buy
@ $8.65, valued at
$64.5k
|
|
| 11/06/2015 |
4
| ANDREWS RONALD ASBURY (Director) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Granted 7,457 options to buy
@ $12.5, valued at
$93.2k
Granted 14,914 options to buy
@ $12.5, valued at
$186.4k
|
|
| 02/04/2014 |
4
| ANDREWS RONALD ASBURY (President, Medical Sciences) has filed a Form 4 on Life Technologies Corp|
Txns:
| Disposed/sold 7,357 shares
@ $76.1312, valued at
$560.1k
Disposed/sold 44,671 options
@ $48.99, valued at
$2.2M
Disposed/sold 21,337 options
@ $48.91, valued at
$1M
Disposed/sold 3,067 restricted stock units
@ $0
Disposed/sold 6,133 restricted stock units
@ $0
Disposed/sold 4,259 restricted stock units
@ $0
Disposed/sold 12,776 restricted stock units
@ $0
Disposed/sold 7,144 restricted stock units
@ $0
Disposed/sold 3,572 restricted stock units
@ $0 |
|
| 01/22/2014 |
4
| ANDREWS RONALD ASBURY (President, Medical Sciences) has filed a Form 4 on Life Technologies Corp|
Txns:
| Disposed/sold 13,546 options to buy
@ $0 |
|
| 04/03/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/02/2013 |
4
| ANDREWS RONALD ASBURY (President, Medical Sciences) has filed a Form 4 on Life Technologies Corp|
Txns:
| Granted 8,509 options to buy
@ $0
Granted 17,035 options to buy
@ $0 |
|
| 02/05/2013 |
4
| ANDREWS RONALD ASBURY (President, Medical Sciences) has filed a Form 4 on Life Technologies Corp|
Txns:
| Exercised 3,572 shares
@ $65.24, valued at
$233k
Paid exercise price by delivering 1,399 shares
@ $65.24, valued at
$91.3k
Exercised 3,572 options to buy
@ $0 |
|
| 05/01/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|